STOCK TITAN

MET Rule 144 Notice: 269 Shares Proposed for Sale via Bernstein on 09/19/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MetLife, Inc. (MET) filed a Form 144 proposing the sale of 269 shares of Common Stock through Bernstein Institutional Services on 09/19/2025, with an aggregate market value of $21,269.83. The shares were acquired on 06/20/2014 from GOLDMAN SACHS and payment was made in cash on 06/25/2014. The filing reports 665,026,054 shares outstanding for the issuer. The document also discloses multiple recent sales by MetLife-related accounts in June and July 2025, including 547 shares sold on 06/20/2025 and 1,024 shares sold on 06/27/2025, showing routine plan and separate-account transactions.

Positive

  • Clear compliance with Rule 144 disclosure requirements including acquisition, payment, broker, and proposed sale details
  • Modest size of the proposed sale (269 shares, $21,269.83) relative to 665,026,054 shares outstanding, indicating immaterial impact on share count

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice for a small proposed sale relative to total shares outstanding; not materially dilutive.

The filing notifies a proposed sale of 269 shares valued at $21,269.83 to be executed on 09/19/2025 via Bernstein Institutional Services. The shares were purchased in 2014 from GOLDMAN SACHS and paid in cash. Reported outstanding shares are 665,026,054, so this proposed transaction represents an immaterial fraction of the float. The filing also lists several executed sales by MetLife-related accounts in June and July 2025 consistent with plan or account rebalancing. For investors, this form is primarily a compliance disclosure rather than a material corporate event.

TL;DR: Filing appears to satisfy Rule 144 disclosure requirements; items disclosed are routine and procedurally compliant.

The notice includes required details: acquisition date (06/20/2014), seller

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does MetLife's (MET) Form 144 say about the proposed sale?

The filing proposes the sale of 269 shares of Common Stock via Bernstein Institutional Services on 09/19/2025 with an aggregate market value of $21,269.83.

When and how were the 269 shares being sold acquired?

The shares were acquired on 06/20/2014 from GOLDMAN SACHS and payment was made in cash on 06/25/2014.

How many MetLife shares are outstanding according to the filing?

The issuer has 665,026,054 shares outstanding as reported in the Form 144.

Does the filing disclose recent related sales by MetLife accounts?

Yes. It lists multiple sales in June and July 2025, including 547 shares on 06/20/2025 and 1,024 shares on 06/27/2025, with corresponding gross proceeds.

Who is the broker handling the proposed sale in the Form 144?

Bernstein Institutional Services LLC at 245 Park Ave, New York, NY is named as the broker for the proposed 09/19/2025 sale.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

51.82B
550.65M
0.25%
91.63%
1.37%
Insurance - Life
Life Insurance
Link
United States
NEW YORK